investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting intratumor heterogeneity in breast cancer
Kornelia Polyak
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Kornelia Polyak
Dana-Farber Cancer Institute
Boston, United States
Related projects
Jeffrey J Fredberg
Epithelial layer jamming in breast cancer cell migration
Breast
Rohit Prakash
Deciphering the epistatic relationships of RAD51 Paralogs in mammary epithelium
Breast
David E Goldgar
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
Breast
Powel Brown
ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast
Peter Sicinski
Cyclin-Dependent Kinases in Oncogenesis
Breast
Mircea Ivan
Role of Hypoxia-Induced miR-210 in Tumor Metabolism
Breast
Stephen J Elledge
Analysis of the Mammalian DNA Damage Response
Breast
Filippo G Giancotti
Mechanisms governing metastatic reactivation of breast cancer.
Breast